In contrast, the tumor-enriched PRDX1+ and HERPUD1+LA-Mac subtypes displayed mixed M1/M2 signatures, suggesting alternative activation states beyond the canonical M1/M2 classification. This evidence concerns the gene PRDX1 and neoplasm.